Although some controversial data of IGF-1 have been reported in Alzheimer disease and age-related diseases [35,36], the administration of IGF-1 or IGF-1 mimetics still appears to be beneficial when IGF-1 resistance occurs in these diseases [34]. This evidence concerns the gene IGF1 and Alzheimer disease.